Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
Surge in Adoption of Next Generation Sequencing (NGS) Solutions for Predictive Diagnosis Transforms the IVD Testing Landscape
save 10 %
* Required Fields
Pay by invoice
Across the world, women live longer than men. The reason behind the difference between male and female life expectancy is unclear, but it seems related partially to biological advantages and partially to environmental and behavioral factors. Even though women outlive men, they are more prone to suffering from ill health and other age-related diseases. Women's healthcare, however, especially in less-developed settings, remains mostly confined to reproductive issues, particularly maternal health. Attention to other significant women’s health issues such as cardiology, reproductive health, and urology is growing rapidly. Overall, the advancements in women’s health diagnostic products are intense, and diagnostic technologies have been subjected to rapid change. Two of the key market drivers are the rising occurrence of lifestyle disorders among women and growing awareness of women-specific health issues. The other drivers include the rise in the number of private diagnostic labs mostly in the emerging nations, health initiatives/drives taken by governments and other health organizations, and new approvals for easy-to-use rapid tests. Nevertheless, the lack of skillful lab professionals and high set-up costs of diagnostic devices/systems are some key restraints to growth in the women’s health diagnostics market. Currently, women’s health diagnostic products are being targeted at markets outside of the traditional hospital or clinical laboratory. In fact, the demand for home healthcare services in women’s health is facing a steady increase, but, at the same time, there is pressure to lower costs and maintain the high quality of the care delivered at home. Continuous improvements in technology are bringing about a number of new diagnostic tests that consolidate high levels of accuracy with rapid, easy-to-use product designs. Breast cancer is one of the leading causes of death in women across the globe and accounts for almost 3% of total deaths among women. Research suggests that out of every 12 women one will develop breast cancer at some point in her life. The risk factors include hormonal effects, age, and genetic predisposition. Overweight women are considered to be at greater risk for developing breast cancer. With increased weight, greater amounts of estrogen are produced by the body. Just as estrogen in HRT increases breast cancer risk, high amounts of estrogen produced by women before menopause also increase the risk of breast cancer.This strategic research service provides the key growth drivers and current competitive landscape in the women's oncology diagnostics market. Also, it covers the market size and growth rate forecast for 2016 and 2021. Study ScopeThe women's oncology diagnostics market has been categorized into point-of-care (POC)/molecular tests, lab instrumentation, drug delivery devices, wearables and patient monitoring devices, and surgical instruments.Key Questions This Study Will Answer:What are the key opportunities that make this an attractive market with significant future revenue potential for companies?What is the growth potential for women’s oncology diagnostics solutions and sub-segments across different geographies?What are the key growth drivers that companies should focus on to remain relevant and competitive in this market?Who are the top game-changing companies in the women’s oncology diagnostics market and what are their leading product portfolios?
US Cardiac Troponin Diagnostics Market, Forecast to 2021
Western European Cardiac Troponin Diagnostics Market, Forecast to 2021
Analysis of the APAC Cardiac Troponin Diagnostics Market, Forecast to 2021
Strategic Insight into the Global Women’s Urology Diagnostics Market, 2017
Strategic Insight into the Global Women’s Cardiology Diagnostics Market, 2017
Strategic Insight into the Global Women’s Reproductive Health Diagnostics Market, 2017
Growth Opportunities in European Prenatal Genetic Testing Market, Forecast to 2021
2017 Customer Attitudes and Adoption Plans of Digital Pathology Technologies
Growth Opportunities in the US Prenatal Genetic Testing Market, Forecast to 2021
Growth Opportunities in APAC Oncology Diagnostics Market, Forecast to 2021
Fill in the fields below to receive a sample report
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.